Organization Program of DiabEtes INsulIN ManaGement

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1500 participants.

Also called NCT01338376

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,500 participants (planned count) (from the registry)
Sponsor
Chinese Diabetes Society (from the registry)
Registry
  • NCT NCT01338376
Other papers using this trial's data
  • Efficacy of structured education in patients with type 2 diabetes mellitus receiving insulin treatment Journal of diabetes, 2014-07 DOI, PubMed 24279284

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01338376. Randomized; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2012-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Organization Program of DiabEtes INsulIN ManaGement
Acronym
OPENING
Condition
Type 2 Diabetes Mellitus
Intervention (Behavioral)
Structured Education
Intervention (Behavioral)
Conventional Diabetes Education
Intervention (Drug)
Scilin®M30
Lead sponsor
Chinese Diabetes Society (class: other)

Record details

Record id
cardio:ct-nct01338376
Content hash
5e3cd08b01b1428184eae85c0adb8b6377ed602c5b24b433c22511e2f6fddb70